AOK-BUNDESVERBAND GBR published tender for Gem completion of drug-related agreements. 130a para. 8 sgb v on certain proprietary medicinal products for oral use in the treatment of oncological diseas

The present tender is the conclusion of medicinal product related agreements pursuant to 130a para. 8 SGB V on certain proprietary medicinal products for oral use in the treatment of oncological diseases. The tender subject agents include dasatinib, erlotinib, nilotinib, pazopanib, sunitinib, everol...

Full description

Saved in:
Bibliographic Details
Published inMENA Report
Format Newsletter
LanguageEnglish
Published Camden Disco Digital Media, Inc 18.02.2016
Subjects
Pharmacy
Proprietary
Online AccessGet full text

Cover

More Information
Summary:The present tender is the conclusion of medicinal product related agreements pursuant to 130a para. 8 SGB V on certain proprietary medicinal products for oral use in the treatment of oncological diseases. The tender subject agents include dasatinib, erlotinib, nilotinib, pazopanib, sunitinib, everolimus and lapatinib with potencies between 5 and 400 mg.
ISSN:2219-0112